Public Calendar: May 27, 2018 - June 2, 2018
This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the Federal Government.
Official Name: Scott Gottlieb, M.D., Commissioner of Food and Drugs
Event Date: 05/29/2018
Location: Silver Spring, MD
Subject: Initiatives Related to the Opioid Crisis
FDA Participant/Group: Yuan, Menglu; Lenihan, Keagan R; Jerrick, Morgan L; Dalpan, Gerald J; Kuethe, Christine; Throckmorton, Douglas C; Fine, Anna; Silvis, Lauren R; Rausch, Paula A; Jenkins, Yolanda K;
Non FDA Participant/Group: Fred Muench, Marcia Lee Taylor(Partnership for Drug-Free Kids);
Event Date: 05/31/2018
Location: Washington, DC
Subject: FDA's Activities to Address Pain Management
FDA Participant/Group: Hertz, Sharon H; Lenihan, Keagan R;
Non FDA Participant/Group: Members of the Pain Management Best Practices Task Force
Event Date: 06/01/2018
Location: Chicago, IL
Subject: American Society of Clinical Oncology Annual Meeting: FDA Approval and Their Incorporation into Clinical Practice
FDA Participant/Group: Rodriguez, Jennifer A;
Non FDA Participant/Group: Media, industry, academia, government and other registered participants
Official Name: Rachel Sherman, M.D., M.P.H.,, Principal Deputy Commissioner
No Significant Event
Official Name: Anna Abram, Deputy Commissioner for Policy, Planning, Legislation, and Analysis
No Significant Event
Official Name: Mark Abdoo , Acting Deputy Commissioner for Global Regulatory Operations and Policy
No Significant Event
Official Name: Jim Sigg, Deputy Commissioner for Operations
No Significant Event
Official Name: Stephen M. Ostroff, M.D., Deputy Commissioner for Foods and Veterinary Medicine
No Significant Event
Official Name: Melinda Plaisier, Associate Commissioner for Regulatory Affairs
No Significant Event
Official Name: Mary Lou Valdez, M.S.M., Associate Commissioner for International Programs
No Significant Event
Official Name: Jennifer Rodriguez, Acting Associate Commissioner for External Affairs
No Significant Event
Official Name: RADM Denise Hinton , Acting Chief Scientist
No Significant Event
Official Name: Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research
No Significant Event
Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research
Event Date: 05/30/2018
Location: Washington, DC
Subject: The Pharmaceutical Research and Manufacturers of America Board Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: N/A
Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health
No Significant Event
Official Name: Susan T. Mayne Ph.D., Director, Center for Food Safety and Applied Nutrition
No Significant Event
Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products
No Significant Event
Official Name: Steven Solomon, Director, Center for Veterinary Medicine
Event Date: 05/29/2018
Location: Washington, D.C.
Subject: Veterinary Issues of Mutual Interest
FDA Participant/Group: Forfa, Tracey H; Flynn, William T; Delancey, Siobhan M;
Non FDA Participant/Group: The Pew Charitable Trusts
Event Date: 05/31/2018
Location: Rockville, MD
Subject: Veterinary Issues of Mutual Interest
FDA Participant/Group: Delancey, Siobhan M; Lucia, Matthew A; Forfa, Tracey H; Oeller, Margaret R; Greenlees, Kevin J; Flynn, William T;
Non FDA Participant/Group: National Turkey Federation Turkey Health Task Force
Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research
No Significant Event
Official Name: Rebecca K. Wood, J.D., Chief Counsel
Event Date: 05/31/2018
Location: Silver Spring, Maryland
Subject: N2 Products Corporation Meeting
FDA Participant/Group: Beshara, Nicholas E; Kettl, David L; Mednick, David; Amatrudo, Vincent A; Bertram, James P; Hyman, Frederick N; Flannery, Ellen J; Edmonds, Amanda B; Adjodha, Michael E; Runner, Mary S; See, Norman A;
Non FDA Participant/Group: Alvin Arzt(N2 Products Corporation); Charles J. Raubicheck(Haug Partners LLP);